Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer. [electronic resource]
- Cancer research Aug 1982
- 3445s-3447s p. digital
Publication Type: Journal Article
0008-5472
Adult Aged Aminoglutethimide--adverse effects Bone Neoplasms--drug therapy Breast Neoplasms--drug therapy Female Humans Middle Aged Nausea--chemically induced Neoplasm Recurrence, Local Palliative Care Quality of Life Sleep Stages--drug effects Tamoxifen--therapeutic use Time Factors